Clinical implementation of the infusion rate individualization of intravenous lipid emulsion

Clinical implementation of the infusion rate individualization of soybean oil-based intravenous lipid emulsion: A multi-center descriptive cohort study - Clinical implementation of the infusion rate individualization of intravenous lipid emulsion

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054236

Enrollment

120

Registered

2024-04-24

Start date

2023-11-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who clinically need intravenous lipid emulsion

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Baseline triglyceride level < 300 mg/dL

Exclusion criteria

Exclusion criteria: Patients with estimated individualized infusion rates less than 10 mL/h or greater than 0.33 g/kg/h

Design outcomes

Primary

Measure	Time frame
Maximum triglyceride concentration on the final day of administration	—

Secondary

Measure	Time frame
Laboratory parameters, including liver function, renal function, and markers of inflammation	—

Countries

Japan

Contacts

Public ContactKeizo Fukushima

Kobe Gakuin University Faculty of Pharmaceutical Sciences

keizo@pharm.kobegakuin.ac.jp078-974-4441

Outcome results